⌘K (Command K) to search

Sign in Sign up free

Insider · CIK 0002005618

DiRaimondo Thomas

Reports to the SEC for 1 company · SAN DIEGO, CA

Transactions

8

Companies

1

Filings

4

CIK

0002005618

Forms 4 and 5

Insider transactions

8 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-01-02	JANXJanux Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−2,505 sh	$13.73	−$34.4K	124,425
2026-01-02	JANXJanux Therapeutics, Inc.A Award	Chief Scientific Officer	AAward	+31.4K sh	—	—	155,825
2026-01-02	JANXJanux Therapeutics, Inc. · Stock option (right to buy)A Award	Chief Scientific Officer	AAward	+110K sh	—	—	109,900
2025-01-02	JANXJanux Therapeutics, Inc.A Award	Chief Scientific Officer	AAward	+24K sh	—	—	129,719
2025-01-02	JANXJanux Therapeutics, Inc. · Stock option (right to buy)A Award	Chief Scientific Officer	AAward	+84K sh	—	—	84,000
2024-09-27	JANXJanux Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−4,325 sh	$46.21	−$200K	98,613
2024-09-27	JANXJanux Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−675 sh	$47.22	−$31.9K	97,938
2024-01-02	JANXJanux Therapeutics, Inc. · Stock Option (right to buy)A Award	Chief Scientific Officer	AAward	+147K sh	—	—	147,000

Recent filings

4

Accepted (ET)
Jan 24
DiRaimondo Thomas0002005618-26-000002
SEC(opens sec.gov)
Jan 34
DiRaimondo Thomas0001415889-25-000673
SEC(opens sec.gov)
Sep 274
DiRaimondo Thomas0001415889-24-024076
SEC(opens sec.gov)
Jan 34
DiRaimondo Thomas0001209191-24-000426
SEC(opens sec.gov)

Companies

1

Janux Therapeutics, Inc.Chief Scientific OfficerJANX

Address

C/O JANUX THERAPEUTICS, INC. 10955 VISTA SORRENTO PARKWAY, SUITE 200

SAN DIEGO, CA, 92130